Risk factors for dementia in Parkinson’s Disease — the overuse of anticholinergic drugs

Jakub J. Malkiewicz, Amadeusz G. Kasprzyk, Damian Waksmundzki, Julia Węgrzynek, Tomasz Chmiela, Joanna Siuda

Research Paper

PDF HTML

Serum amino acid profiling in differentiating clinical outcomes of multiple sclerosis

Łukasz Rzepiński, Piotr Kośliński, Mariusz Kowalewski, Marcin Koba, Zdzisław Maciejek

Research Paper

PDF HTML

Association between within-visit blood pressure variability, stroke, coronary heart disease, and cardiovascular mortality

Bhrugun Anisetti, Hossam Youssef, Ahamed M. Elkhair, Michelle P. Lin

Research Paper

PDF HTML

Differences in diffusion tensor imaging parameters of brain white matter tracts between patients with myotonic dystrophy type 1 and type 2 — a retrospective single-centre study

Edyta Maj, Tomasz Wolak, Joanna de Meulder, Katarzyna Janiszewska, Mikołaj Wojtaszek, Anna Kostera-Pruszczyk, Marek Gołębiowski, Anna Łusakowska

Research Paper

PDF HTML

To know or not to know? Opinions of patients with Parkinson’s Disease on disclosing risk of phenoconversion in RBD

Aneta Marcinkowska, Andrzej Bogucki, Aleksandra Kroemeke, Agata Gajos

Research Paper

PDF HTML

Potential use of glucocorticosteroids in CSF1R mutation carriers – current evidence and future directions

Jarosław Dulski, E. Richard Stanley, Violeta Chitu, Zbigniew K. Wszolek

View Point

PDF HTML

Atypical motor presentation of Huntington’s Disease

Katarzyna Śmiłowska, Daniel van Wamelen

Letter to the Editors

PDF HTML

Neurologists should retain diagnostic and therapeutic management of migraines

Josef Finsterer

Letter to the Editors

PDF HTML

Response to ‘Neurologists should retain diagnostic and therapeutic management of migraines’

Magdalena Boczarska-Jedynak

Response to Letter to the Editors

PDF HTML